CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
69.15
+0.72 (1.05%)
At close: Oct 17, 2025, 4:00 PM EDT
68.70
-0.45 (-0.65%)
After-hours: Oct 17, 2025, 7:59 PM EDT
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $6.29 billion as of October 17, 2025. Its market cap has increased by 61.55% in one year.
Market Cap
6.29B
Enterprise Value
4.78B
1-Year Change
61.55%
Ranking
Category
Stock Price
$69.15
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $6.29B, an increase of 1,022.87%. That is a compound annual growth rate of 30.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 6.29B | 87.21% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
| Oct 19, 2016 | 560.10M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |